Analysts move to sidelines from Inovio after FDA paused its COVID-19 vaccine trial plans
Analysts move to sidelines from Inovio after FDA paused its COVID-19 vaccine trial plans
SeekingAlpha
0 shares
1 views
You might like
Related news coverage
NA Proactive news snapshot: Aequus Pharmaceuticals, Thunderbird Entertainment, American Manganese, Energy Fuels UPDATE ...
Aequus Pharmaceuticals Inc (CEV:AQS) (OTCQB:AQSZF) announced Monday that it has submitted new medical device license (MDL)..
Proactive Investors